ZURICH (Reuters) – Germany’s CureVac filed in Switzerland for a rolling review of its COVID-19 vaccine candidate, the Swiss drugs regulator Swissmedic said on Monday, as yet another maker of...

(Reuters) – Europe’s drugs regulator said on Tuesday it was expecting to give an opinion before the summer on whether Gilead Sciences’ remdesivir can be used to treat COVID-19 patients...